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Summary 
Most inbred strains of mouse infected with the intestinal nematode Trichuris muris are resistant 
to infection expelling the parasite before adult worms establish.  However, a few susceptible strains 
exist that are incapable of worm expulsion and harbor chronic infections of mature adult worms. 
Analyses of in vitro cytokine production  by cells  from the draining  lymph  node (mesenteric 
lymph node) have indicated  that  expulsion phenotype is tightly correlated with  the selective 
expansion  of helper T  cells  (Th) of the Thl  or Th2 cell subset within  the mesenteric lymph 
node, resulting in susceptibility and resistance to T. muffs, respectively. We have now confirmed 
and extended our in vitro observations in a series of experiments involving the in vivo manipulation 
of host cytokine levels. Depletion of interferon (IFN)-'y in normally susceptible mice resulted 
in expulsion of the parasite, representing the first evidence for a role for IFN-3r in the establishment 
of chronic helminth infection. Blocking interleukin (IL)-4 function in normally resistant animals 
prevented the generation of a protective immune response allowing adult stages of the parasite 
to develop. Conversely the administration of IL-4 to a normally susceptible host facilitated expulsion 
and indeed enabled established adult worms to be expelled when administered late in infection. 
In all cases assessment of a variety of in vivo parameters indicative of a Thl- or Th2-type response 
(parasite-specific  immunoglobulin  (Ig) G2a and the parasite-specific  IgG1,  total IgE levels and 
intestinal mastocytosis, respectively) demonstrated that the in vivo modulation ofa Thl- or Th2- 
specific cytokine allowed the reciprocal Th cell subset to expand and become dominant  with 
dramatic  consequences for worm  expulsion. 
M 
urine CD4 § Th cells can be divided into two distinct 
subsets (1); Thl-type cells produce IL-2, IFN-'y, and 
lymphotoxin, while Th2 cells produce IL-4, IL-5, IL-9, and 
IL-10 (2, 3). Development of an appropriate Th cell response 
is critical to the outcome of infection as exemplified by the 
cecal dwelling nematode parasite Trichuris muris in the mouse 
where Th2-type responses are associated with host protec- 
tion while Thl  responses are associated with susceptibility 
to infection  (4,  5).  Although  resistance to other intestinal 
helminth parasites has also been shown to be associated with 
the activation of Th2 cells (6, 7, 8), the T. tour/s-mouse model 
is  unique  in  that  it  is  the  only  nematode  system  where 
reciprocal activation of Th cell subsets in relation  to acute 
and chronic infection has been described. We here assess the 
roles of key Thl and Th2 cytokines (IFN-'y and IL-4) in the 
development of protective immunity by a series of in vivo 
studies. We demonstrate that IFN-'y plays an important role 
in the establishment  of chronic trichuriasis  while the pres- 
ence of IL-4 is essential in the development of a protective 
Th2-type response. 
Materials and Methods 
Animals.  Male  AKK  and  BALB/K  mice  were  purchased 
from Harlan Olac Ltd. (Bicester, Oxon, UK) and infected when 
6-8-wk-old. 
Parasite.  The maintenance of T. muris and the method used for 
infection were as described by Wakelin (9). Mice were killed at 
various time points after infection and worm burdens were assessed 
as previously described (10). 
Cytokine and Antibody Reagents.  IFN-~/levels were depleted in 
vivo using the rat anti-IFN-3~ mAbs XMG-6 (11) or R46A2 (12) 
injected intraperitoneally as detailed in the text. Ib4 function was 
blocked in vivo by intravenous injection of the rat anti-Ib4 receptor 
mAb M1 (13). Ib4 was delivered in vivo in the form of a complex 
as previously described (14, 15). Briefly, 10 #g Ib4 was complexed 
with 50/~g 11Bll  (16), 1Dll.2 (17) (both neutralizing  anti-IL-4 
mAbs), or BVD6.24G2.3 (18) (24G2.3, a nonneutralizing  mAb) 
before intravenous injection. 
ELISAs.  Parasite-specific  IgG1 and IgG2a levels were conducted 
as previously described (19). Briefly adult T. muris excretory/secre- 
tory (E/S) antigen was used as the target antigen at 0.25/~g/well 
and sera double diluted through eight dilutions from 1/20.  IgG1 
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mouse  IgG1  (Serotec  Ltd.,  Oxford,  UK)  and  IgG2a with  bi- 
otinylated rat anti-mouse IgG2a (AMS Biotechnology, Witney, 
Oxon, UK) followed by streptavidin  peroxidase (Boehringer Mann- 
heim UK,  East Sussex,  UK). 
Total IgE levels were measured by sandwich ELISA using a rat 
mAb to murine IgE (Serotec Ltd.) as the capture antibody, goat 
anti-mouse IrE peroxidase (Nordic Immunological Labs, Maiden- 
head Berks, UK) as the detection antibody and an IgE monoclonal 
antibody specific for DNP (Serotec  Ltd.) as standard. 
Histology.  Intestinal mast cells were counted after conventional 
staining of carnoys-fixed tissue with 0.5% toluidine blue, pH 0.3. 
Statistical Analysis.  Significant differences between experimental 
groups  were  calculated  using  the  Mann-Whitney  U-test  with 
p  >0.05  considered nonsignificant. 
Resu|ts 
IFN-9" Is  Critical  in Determining  the Chronicity of T.  muris 
Infection.  To assess the role of IFN-3' in promoting suscep- 
tibility to infection we depleted susceptible (Thl-dominated) 
AKR mice with the anti-IFN-3' monoclonal antibody XMG-6 
(11) as detailed in Fig.  1 a. Neutralization  of IFN-3' in vivo 
resulted in expulsion of the parasite by day 35.  Mice treated 
with an isotype-matched mAb (GLl13)  and mice receiving 
saline harbored full complements of mature adult worms at 
levels not significantly different from the infectivity level of 
88.8  _+  8.7  estimated  on  day 10  after infection  (p >0.05). 
In vivo depletion  of IFN-3' not  only altered  the  expulsion 
phenotype  of AKR  mice but  also  modified  their  parasite- 
specific antibody responses as shown in Fig. 2 a. IgG1 levels, 
under  the control  of Th2  cell cytokines  (20),  were  similar 
in all infected  groups.  However the parasite-specific IgG2a 
response,  controlled  by the Thl  cytokine IFN-3' (20),  was 
considerably  depressed  in  IFN-'y depleted  mice  (Fig.  2  b) 
providing further evidence for the dependency of the murine 
IgG2a response on IFN-y. Repeat experiments using a dif- 
ferent susceptible strain of mouse, B10.BR, and the anti-IFN-y 
mAb R46A2  (12)  (0.4  mg/injection  weekly from day 0  to 
day 28 after infection) confirmed the effects of depleting IFN-y 
on worm expulsion and antibody isotype production  (data 
not shown).  These results represent the first demonstration 
of a critical role for IFN-3, in determining chronic intestinal 
helminth  infection. 
Blocking IL-4 Function In Vivo Prevents Expulsion  ofT. muris. 
The presence of IL-4 during T  cell differentiation  has been 
shown to be important  in the development of Th2-type re- 
sponses both in vitro (21) and in vivo (22). Therefore to assess 
the Th2 cytokines critical in determining resistance to T. muris 
infection  we  treated  normally  resistant  (Th2-dominated) 
BALB/K mice with the anti-IL-4 receptor mAb M1 (13) or 
an isotype control (GLl17)  as detailed in Fig.  1 b. All mice 
in which [L-4 functions had been blocked still harbored con- 
siderable numbers of adult worms 36 d after infection in con- 
trast to control GLl17-treated mice from which  no worms 
were recovered.  T. muris-specific  IgG1 responses were similar 
in both groups;  a very strong  specific IgG2a response was 
seen in  mice given M1,  while  no  IgG2a response was  de- 
tected in control GL117-treated mice (Fig. 2, c and d). In ad- 
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Figure  1.  Adult worm burdens recovered from susceptible and resis- 
tant strains of mice after in vivo manipulation of cytokines levels. (a) Sus- 
ceptible AKR mice were infected orally with 400 T. muris eggs on day 
0 and injected with 1 mg anti-IFN-3' mAb XMG-6 intraperitoneally on 
days 0 and 7 (anti-IFN-g x  2), or XMG-6 (anti-IFN-g x  5), control mAb 
GLl13 or PBS on days 0, 7, 14, 21, and 28 post infection. Adult worm 
burdens were estimated on day 35 post infection and are presented as mean 
values +SE, six mice/group. (b) Resistant BALB/K mice were infected 
as above and injected with 3 mg anti-IL-4 receptor mAb M1 (anti-IL4 R) 
or control mAb GLl17 (control) intravenously on days 0, 3, 6, 9, 12, and 
15. Mean adult worm burdens  _+  SE for five individuals/group on day 
36 post infection are shown. (c) Susceptible AKR mice were infected as 
above and injected intravenously on days 8 and 11 post infection with 10 
#g IL-4 in the form of a complex with 50 p.g of the neutralizing anti-IL-4 
mAbs 111311 (IL-4 complex; llBll/IL4),  or 1Dll.2 (11.,4  complex; 1DI1.2/IL 
4). Control groups received equivalent amounts of anti-IL-4 mAb or I1.-4 
as found in the complex (control anti-IL4,  11Bll ; control anti-IL4,  IDli.2; 
control, IL4) or a control II.-4  complex consisting of 10/zg I1.-4  complexed 
with 50 ~g of the nonneutralizing anti-IL-4  mAb 24G2.3 (control  11.,4 com- 
plex). Results are given as day 36 post infection mean worm burdens +SE 
for group sizes of four or five mice. (d) Susceptible  AKR mice with patent 
adult infections on day 35 post infection as assessed by the presence of 
eggs in feces, were injected with II.-4 complexes or control reagents as 
described in c on days 35 and 38 post infection. Mean worm burdens _+ 
SE on day 45 are shown, four or five  mice per group except for the 1Dll.2/ 
IL-4 group where n  =  3. 
dition,  the intestinal mast cell response and total IgE levels 
(both Th2-controlled  responses  [23-26])  were depressed to 
levels significantly below  normal in  Ml-treated  animals  (p 
<0.05  and p  <0.005,  respectively;  Fig.  3,  a  and  b).  These 
results strongly suggest that blocking IL-4 function in vivo 
enabled a nonprotective Thl-type response to develop, resulting 
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Figure  2.  Parasite-specific  serum IgG1 and IgG2a responses of suscep- 
tible and resistant strains of mouse after the in vivo manipulation of the 
IFN-qr or IL4 response. (a and b) Susceptible AKR mice were infected 
and depleted of IFN-"/as described in Fig. 1 a. Normal uninfected mice 
received weekly intraperitoneal injections of PBS. Day 35 post infection 
anti-T, muris IgG1 levels are shown in a, and the ]gG2a response in b. 
(c and d) Resistant BALB/K mice were infected and their Ib4 response 
blocked as described  in Fig. I b. Normal mice were given equivalent  injec- 
tions of PBS. Anti-T. muris lgG1 levels on day 36 post infection are shown 
in c and IgG2a levels in d. Data are represented as the mean OD at ;k 
405 nm  _+  SE against dilution of sera. 
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Figure 3.  Intestinal mast cell numbers and total IgE levels in BALB/K 
mice after in vivo blocking of their II.-4  response. Resistant BALB/K mice 
were infected  and their II:4 response  blocked as described  in Fig. 1 b. Normal 
mice were given equivalent injections of PBS. Mean numbers of mast cells 
per 20 crypt units (CU)  +  SE on day 36 post infection are shown in a 
and total IgE levels (mean _+  SE) in b. 
in  elevated  IgG2a  levels,  depressed  IgE  levels,  depressed 
mastocytosis, and susceptibility to infection. Repeat experi- 
ments confirmed the effects of blocking IL-4 function in vivo 
using M1  (data not  shown). 
Administration of lL-4 to Susceptible Mice Facilitates Expul- 
sion.  To confirm the importance of ILo4 in mediating resis- 
tance to T  muris infection, we treated normally susceptible 
AKIL mice with IL-4 in the form of a complex (detailed in 
Fig.  1,  c and  d).  The IL-4 complex methodology (14,  15) 
was selected as injection of mice with complexes of IL-4 and 
neutralizing anti-IL-4 mAbs increases the duration and mag- 
nitude of the IL-4-mediated effects in vivo. Fig.  1 c shows 
the worm burdens recovered from normally susceptible AKtL 
mice when injected early in infection (days 8 and  11) with 
10/zg of IL-4 complexed with 11Bll (16) or 1Dll.2 (17) (both 
neutralizing anti-IL-4 mAbs) or 24G2.3 (18) (a nonneutra- 
lizing mAb) or a variety of controls including the mAbs and 
IL-4 alone.  Mice treated with  11B11/IL-4 or  1Dll.2/IL-4 
expelled their infection by day 36. In contrast all the control 
groups harbored mature adult worms at levels not significantly 
different from the  day  11  infectivity level of 93.3  _+  12.3 
(p >0.05).  10/zg of IL-4 alone was insufficient to promote 
protective immunity underlining the increased effectiveness 
of cytokine administration using the complex methodology 
(14, 15). Thus, administration of IL-4 at an early stage after 
infection is sufficient to allow normally susceptible mice to 
develop a very effective protective immune response. To de- 
termine whether IL-4 could influence an established adult 
T. muris infection, mice with patent infections were injected 
with IL-4 complexes. As shown in Fig. I d, 11Bll/IL-4 com- 
plex treatment induced complete expulsion in most mice, with 
just a few sterile worms remaining in two of the five individ- 
uals. It has recently been shown that treatment of Leishmania 
major-infected  mice with a cytokine (IL-12) at the time of 
parasite inoculation can prevent the development of a chronic 
infection  (27).  Data  presented  here  now  establish  that  a 
cytokine (IL-4) can also be used as effective therapy for an 
established infection. 1Dll.2/IL-4 complexes were less effec- 
tive against  adult  parasites  than  11B11/IL-4 complexes, al- 
though significantly few worms were also recovered in these 
mice compared with control complex-treated mice (p  =  0.05). 
These observations do not exclude the possibility that IL-4 
has a direct toxic effect on T. muris from the possibility that 
]L-4 enhances host protection against this parasite. However 
the latter possibility is supported by recent studies that show 
that 11Bll/IL-4 complexes promote the expulsion of Helig- 
mosomoides polygyrus adults during  a primary infection and 
that this effect is blocked by the mAb M1 that inhibits IL-4 
receptor function but would not be expected to bind to any 
existing nematode IL-4 receptor (Urban, J. F., Jr., and F. D. 
Finkelman, manuscript in preparation). In addition, the ad- 
ministration of IL-4 complexes to nude mice infected with 
T  muris failed to induce worm loss  (data  not  shown). 
Discussion 
We have previously reported the polarization of the Th 
cell response in murine trichuriasis towards Th2 cells in resis- 
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tible to  T. muris  (4,  5).  These observations were based  on 
the cytokine profiles of cells from the lymph node draining 
the site of infection after restimulation in vitro. The results 
presented here significantly substantiate and extend these earlier 
findings demonstrating that the IL-4/IFN-'y balance in vivo 
is critical in determining the type of Th cell response gener- 
ated and thus the outcome of infection. The mechanisms in- 
volved in polarizing the Th cell response such that some strains 
of mouse mount a dominant Th2-type response while in others 
Thl cells prevail remain unknown. Many suggestions have 
been put forward including differences in APCs (28-30), differ- 
ences in antigenic epitopes (31, 32),  and the local cytokine 
environment present at the time of initial T  cell activation 
(21, 33).  Clearly, in our system the presence  of IL-4 early 
in infection is a critical component in the generation of a 
protective Th2-type response,  with the "non-B, non-T" cell 
source of IL-4 being an exciting area of current research (34, 
35).  Moreover,  IL-4 appears  to play an important role in 
modulating the host protective immune response to T. muris 
even in the face of established chronic adult worm infections. 
Although Th2 cytokines have been shown to be impor- 
tant in resistance to other intestinal helminth infections (6-8), 
most notably in resistance to challenge infection with 11. poly- 
gyrus (36), the uniqueness of the T. muris-mouse  model lies 
in the ability to study factors promoting both the develop- 
ment of a Th2-type response resulting in resistance to infec- 
tion and a Thl-type response, resulting in chronic infection. 
As such, murine trichuriasis provides  a powerful model for 
the study of immune responses to large multicellular helminth 
parasites and demonstrates the reciprocal relationship between 
host immunity and cytokine production to that seen in mice 
infected with the protozoan parasite L.  major,  where selec- 
tive expansion of the Thl or Th2 cell subset leads to disease 
resolution or fatal dissemination, respectively  (37,  38). 
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